Search Results 1541-1550 of 18709 for autoimmune hepatitis

  1. Assessing Pre-existing Antibodies to AAV in a Population of Patients With PKP2-Associated ARVC - Mayo Clinic

    History of clinically significant liver disease, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or tuberculosis infection. Previously ...

  2. Fostemsavir (oral route) - Mayo Clinic

    Liver disease (eg, hepatitis B or C infection), history of—Use with caution. May make these conditions worse. Back to top. Proper Use. Take this medicine ...

  3. A closer look at sarcopenia and the role of exercise in liver transplant candidates - Mayo Clinic

    ... liver disease (ESLD) awaiting liver transplant. The results of that study ... liver disease." Perceptions about exercise among liver transplant ...

  4. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab - Mayo Clinic

    - No known active liver disease; e.g., due to hepatitis B virus (HBV), hepatitis C virus (HCV), autoimmune hepatic disorders, or sclerosing cholangitis - ...

  5. Fluticasone, umeclidinium, and vilanterol (inhalation route) - Mayo Clinic

    Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Back to top. Proper Use. Inhaled ...

  6. A Study to Evaluate the Effectiveness and Safety of Panzyga in Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    Severe liver disease, with signs of ascites and/or hepatic encephalopathy. ... Patients found to be chronic carriers of hepatitis B virus (HBV), defined by ...

  7. Liver failure and transplant in children - Mayo Clinic News Network

    This edition of the Mayo Clinic Q&A podcast covers liver disease and liver transplant in children. Guests on the podcast are three Mayo Clinic transplant ...

  8. Science Saturday: An anti-cancer establishment - Mayo Clinic News Network

    ... hepatitis B or hepatitis C infections that have caused liver scarring (cirrhosis). For this reason, "liver disease is quite common in Africa, especially sub ...

  9. A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis - Mayo Clinic

    study and for 1 month after treatment discontinuation. Exclusion Criteria: Liver-related: 1. Documented causes of chronic liver disease other than NASH 2 ...

  10. Publications - Amer N. Kalaaji, M.D. - Mayo Clinic

    Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders. Dermatol Clin. 2011 Oct; 29(4):591-8 ...